Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03567421 · ClinicalTrials.gov registry record
Ureteral Stenting After Ureteroscopy for Stone Treatment, A Global Perspective on Indications and Outcomes
A clinical trial, sponsored by Société Internationale d'Urologie.
- Completed
- Registry status
- 2,348
- Enrollment target
NCT03567421: Completed study, sponsored by Société Internationale d'Urologie.
NCT03567421 is a clinical trial that has completed, run by Société Internationale d'Urologie. The registered enrollment target is 2,348 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03567421 has completed, sponsored by Société Internationale d'Urologie.
- COMPLETED
- Registry status
- 2,348 participants
- Enrollment target
Study Summary
Background: The exit strategy after ureteroscopy for stone treatment remains a topic for discussion. Current EAU guidelines on urolithiasis state that postoperative stenting is indicated in patients at increased risk of postoperative complications. Stenting is not considered necessary in all other cases, and after uncomplicated procedures. Objective: To analyse the postoperative ureteral stenting strategy in clinical practice looking at the indication, type of stents used and the duration of stenting after ureteroscopy for stone treatment. Furthermore, the investigators will examine in what setting the stents are being removed postoperatively. Study design: This study is a prospective, observational, international, multicentre registry study executed by uCARE. Study population: All patients \>18 years with a ureter or renal stone who are planned for ureteroscopic treatment by semi-rigid and/or flexible ureteroscopy are eligible for this study.
Primary Outcome
This number will be reported as a % of the total patients enrolled.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,348 participants |
| Start Date | 2018-06-07 |
| Est. Completion | 2019-08-31 |
What the finished NCT03567421 record still lists
NCT03567421 is an observational study that tracks outcomes without assigning an intervention. Its 2,348 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03567421 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03567421 about?
NCT03567421 is a clinical study titled "Ureteral Stenting After Ureteroscopy for Stone Treatment, A Global Perspective on Indications and Outcomes". Background: The exit strategy after ureteroscopy for stone treatment remains a topic for discussion. Current EAU guidelines on urolithiasis state that postoperative stenting is indicated in patients at increased risk of postoperative complications. Stenting is not considered necessary in all other c...
What is the current status of trial NCT03567421?
This trial is currently completed. The enrollment target is 2,348 participants. The study started on 2018-06-07. Estimated completion is 2019-08-31.
Who is sponsoring clinical trial NCT03567421?
This trial is sponsored by Société Internationale d'Urologie, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00025935 · 2,350 participants
Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder
- NCT03099850 · 2,345 participants
Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies
- NCT06679140 · 2,330 participants · Phase 3
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- NCT05868421 · 2,376 participants · NA
Veteran Social Support for Enhancing Use of Smoking Cessation Treatment
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI